ARVN
Price
$8.29
Change
-$0.02 (-0.24%)
Updated
Sep 18 closing price
Capitalization
542.05M
51 days until earnings call
Intraday BUY SELL Signals
CLDX
Price
$38.24
Change
-$0.74 (-1.90%)
Updated
Sep 18 closing price
Capitalization
3B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARVN vs CLDX

ARVN vs CLDX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARVN vs. CLDX commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CLDX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($3B) has a higher market cap than ARVN($542M). CLDX YTD gains are higher at: 40.795 vs. ARVN (-30.101). ARVN has higher annual earnings (EBITDA): -13.3M vs. CLDX (-322.43M). CLDX has more cash in the bank: 718M vs. ARVN (568M). CLDX has less debt than ARVN: CLDX (4.9M) vs ARVN (8M). ARVN has higher revenues than CLDX: ARVN (317M) vs CLDX (158K).
ARVNCLDXARVN / CLDX
Capitalization542M3B18%
EBITDA-13.3M-322.43M4%
Gain YTD-30.10140.795-74%
P/E Ratio31.87N/A-
Revenue317M158K200,633%
Total Cash568M718M79%
Total Debt8M4.9M163%
FUNDAMENTALS RATINGS
ARVN vs CLDX: Fundamental Ratings
ARVN
CLDX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8398
PRICE GROWTH RATING
1..100
6142
P/E GROWTH RATING
1..100
49100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARVN's Valuation (80) in the Biotechnology industry is in the same range as CLDX (94). This means that ARVN’s stock grew similarly to CLDX’s over the last 12 months.

ARVN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLDX (100). This means that ARVN’s stock grew similarly to CLDX’s over the last 12 months.

ARVN's SMR Rating (83) in the Biotechnology industry is in the same range as CLDX (98). This means that ARVN’s stock grew similarly to CLDX’s over the last 12 months.

CLDX's Price Growth Rating (42) in the Biotechnology industry is in the same range as ARVN (61). This means that CLDX’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's P/E Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for CLDX (100). This means that ARVN’s stock grew somewhat faster than CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCLDX
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 10 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
83%
COMPARISON
Comparison
Sep 20, 2026
Stock price -- (ARVN: $8.29 vs. CLDX: $38.24)
Brand notoriety: ARVN and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 246% vs. CLDX: 279%
Market capitalization -- ARVN: $542.05M vs. CLDX: $3B
ARVN [@Biotechnology] is valued at $542.05M. CLDX’s [@Biotechnology] market capitalization is $3B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green while CLDX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while CLDX’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 5 bearish.
  • CLDX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than CLDX.

Price Growth

ARVN (@Biotechnology) experienced а -1.89% price change this week, while CLDX (@Biotechnology) price change was +3.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.53%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +7.13%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 10, 2026.

CLDX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ARVN
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RWM14.160.07
+0.50%
ProShares Short Russell2000 (RWM)
BOTZ35.11-0.01
-0.01%
Global X Robotics & Artificial Intelligence ETF (BOTZ)
BAMO34.69N/A
-0.01%
Brookstone Opportunities ETF (BAMO)
CSM87.49-0.09
-0.10%
ProShares Large Cap Core Plus (CSM)
TSES31.25-0.06
-0.20%
Truth Social American Energy Security ETF (TSES)

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.24%
AXON - ARVN
46%
Loosely correlated
-1.27%
VCYT - ARVN
46%
Loosely correlated
-1.91%
KURA - ARVN
45%
Loosely correlated
+0.09%
OLMA - ARVN
45%
Loosely correlated
-0.81%
BCYC - ARVN
45%
Loosely correlated
-0.82%
More